EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells

Roberta Manco iD, Luciana D'Apice iD, Maria Trovato iD, Lucia Lione iD, Erika Salvatori iD, Eleonora Pinto iD, Mirco Compagnone iD, Luigi Aurisicchio iD, Piergiuseppe De Berardinis, Rossella Sartorius iD

Viruses · 2023

DOI: 10.3390/v15030672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Roberta Manco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Naples, Italy. Hauptthemen laut MEDLINE: Membrane Proteins, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FESR PON “Ricerca e Innovazione”, Dottorati Innovativi con caratterizzazione Industriale, “Luigi Vanvitelli” Campania University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated antigens (TAAs) represent attractive targets in the development of anti-cancer vaccines. The filamentous bacteriophage is a safe and versatile delivery nanosystem, and recombinant bacteriophages expressing TAA-derived peptides at a high density on the viral coat proteins improve TAA immunogenicity, triggering effective in vivo anti-tumor responses. To enhance the efficacy of the bacteriophage as an anti-tumor vaccine, we designed and generated phage particles expressing a CD8+ peptide derived from the human cancer germline antigen NY-ESO-1 decorated with the immunologically active lipid alpha-GalactosylCeramide (α-GalCer), a potent activator of invariant natural killer T (iNKT) cells. The immune response to phage expressing the human TAA NY-ESO-1 and delivering α-GalCer, namely fdNY-ESO-1/α-GalCer, was analyzed either in vitro or in vivo, using an HLA-A2 transgenic mouse model (HHK). By using NY-ESO-1-specific TCR-engineered T cells and iNKT hybridoma cells, we observed the efficacy of the fdNY-ESO-1/α-GalCer co-delivery strategy at inducing activation of both the cell subsets. Moreover, in vivo administration of fdNY-ESO-1 decorated with α-GalCer lipid in the absence of adjuvants strongly enhances the expansion of NY-ESO-1-specific CD8+ T cells in HHK mice. In conclusion, the filamentous bacteriophage delivering TAA-derived peptides and the α-GalCer lipid may represent a novel and promising anti-tumor vaccination strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsNeoplasmsHumansMiceAnimalsCD8-Positive T-LymphocytesGalactosylceramidesAntigens, NeoplasmPeptidesMice, TransgenicAntibodies

Stichwörter der Autor:innen

CD8+ T cellNY-ESO-1alpha-GalactosylCeramidefilamentous bacteriophageiNKTvaccine

Substanzen

alpha-galactosylceramideMembrane ProteinsGalactosylceramidesAntigens, NeoplasmPeptidesAntibodies

Autor:innen und Institutionen

  • Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), 80131 Naples, Italy.
  • Takis Biotech, 00128 Rome, Italy.
  • Neomatrix Biotech, 00128 Rome, Italy.

ORCID-Profile: Roberta Manco, Luciana D'Apice, Maria Trovato, Lucia Lione, Erika Salvatori, Eleonora Pinto, Mirco Compagnone, Luigi Aurisicchio, Rossella Sartorius

Förderung

  • FESR PON “Ricerca e Innovazione”
  • Dottorati Innovativi con caratterizzazione Industriale
  • “Luigi Vanvitelli” Campania University

Zitieren

APA

Manco, R., D'Apice, L., Trovato, M., Lione, L., Salvatori, E., Pinto, E., Compagnone, M., Aurisicchio, L., De Berardinis, P., & Sartorius, R. (2023). Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells. Viruses. https://doi.org/10.3390/v15030672

Vancouver

Manco R, D'Apice L, Trovato M, Lione L, Salvatori E, Pinto E, et al. Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells. Viruses. 2023. doi:10.3390/v15030672

BibTeX
@article{Manco2023,
  author = {Manco, Roberta and D'Apice, Luciana and Trovato, Maria and Lione, Lucia and Salvatori, Erika and Pinto, Eleonora and Compagnone, Mirco and Aurisicchio, Luigi and De Berardinis, Piergiuseppe and Sartorius, Rossella},
  title = {Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15030672}
}
Kostenlos starten →